P21, Bcl-2, and the IPI, but not Bcl-6, predict clinical outcome in DLBCL treated with rituximab(R)-CHOP: Long-term followup from E4494J. N. Winter, L. Zhang,S. Li, V. Aurora,D. Variakojis, B. Nelson,M. Krajewska, T. Habermann,R. I. Fisher,E. Weller,J. C. Reed,S. J. Horning,R. D. GascoyneANNALS OF ONCOLOGY(2008)引用 8|浏览9暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要